Mekinist 2 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F39U9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,517
Award facts
- Contract value 100% obligated
- $21,516.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,516.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Mekinist 2 mg tablets (quantity: 30 units). This non-set-aside contract is scheduled for completion by February 11, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense healthcare enterprise.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related medical commodities to support military healthcare programs worldwide. AmerisourceBergen's competitively awarded contracts with DLA demonstrate its capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains, including oncology, endocrinology, and other specialized medical treatments serving military treatment facilities and defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F39U9?
SPE2DR26F39U9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F39U9 worth?
The government has obligated $21,517 on SPE2DR26F39U9.
Is contract SPE2DR26F39U9 an order under another contract?
Yes. SPE2DR26F39U9 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F39U9 competed?
The extent of competition for SPE2DR26F39U9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award